Literature DB >> 11888925

A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice.

Agnàs Gouble1, Solàne Grazide, Fabienne Meggetto, Pascale Mercier, Georges Delsol, Dominique Morello.   

Abstract

AUF1/heterogeneous nuclear ribonucleoprotein D (hnRNPD) binds to adenylate uridylate-rich elements contained in the 3' untranslated region of many short-lived mRNAs. This binding has been shown in vitro to control the stability of adenylate uridylate-rich element-containing mRNAs, including mRNAs encoding proto-oncogenes, cytokines, or other signaling molecules. However, no studies have yet been undertaken to identify the mRNAs subject to AUF1-mediated regulation in vivo. The purpose of our study was to investigate the biological functions of AUF1. Thus, we derived transgenic (Tg) mice, which overexpress one isoform of AUF1, the p37(AUF1). Mice of the three Tg lines analyzed exhibit altered levels of expression of several target mRNAs, such as c-myc, c-jun, c-fos, granulocyte macrophage colony-stimulating factor, and tumor necrosis factor alpha. The Tg line with the highest amount of Tg p37(AUF1) protein developed sarcomas. The tumors strongly expressed AUF1 Tg protein and Cyclin D1. Taken together, our data show that: (a) AUF1 is a key regulatory factor of gene expression in vivo; and (b) the deregulation of this heterogeneous nuclear ribonucleoprotein leads to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888925

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  59 in total

Review 1.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

2.  ARED 2.0: an update of AU-rich element mRNA database.

Authors:  Tala Bakheet; Bryan R G Williams; Khalid S A Khabar
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

3.  Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity.

Authors:  Isabel López de Silanes; Jinshui Fan; Craig J Galbán; Richard G Spencer; Kevin G Becker; Myriam Gorospe
Journal:  Gene Expr       Date:  2004

Review 4.  The role of AUF1 in regulated mRNA decay.

Authors:  Frances M Gratacós; Gary Brewer
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Nov-Dec       Impact factor: 9.957

5.  AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding protein.

Authors:  Sebastiaan van Zalen; Alyssa A Lombardi; Grace R Jeschke; Elizabeth O Hexner; J Eric Russell
Journal:  Mech Dev       Date:  2015-02-23       Impact factor: 1.882

6.  The superoxide dismutase 1 3'UTR maintains high expression of the SOD1 gene in cancer cells: The involvement of the RNA-binding protein AUF-1.

Authors:  Shuyu Zhang; Jing Xue; Jie Zheng; Shuai Wang; Jundong Zhou; Yang Jiao; Yangyang Geng; Jinchang Wu; Bethany N Hannafon; Wei-Qun Ding
Journal:  Free Radic Biol Med       Date:  2015-04-20       Impact factor: 7.376

7.  MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT.

Authors:  Huda H Al-Khalaf; Abdelilah Aboussekhra
Journal:  J Biol Chem       Date:  2014-09-26       Impact factor: 5.157

Review 8.  Role of CSF-1 in progression of epithelial ovarian cancer.

Authors:  Setsuko K Chambers
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 9.  Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation.

Authors:  Elizabeth J F White; Gary Brewer; Gerald M Wilson
Journal:  Biochim Biophys Acta       Date:  2012-12-14

10.  Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach.

Authors:  Krystyna Mazan-Mamczarz; Patrick R Hagner; Bojie Dai; William H Wood; Yongqing Zhang; Kevin G Becker; Zhenqui Liu; Ronald B Gartenhaus
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.